pd 98059 has been researched along with Metastase in 25 studies
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one: inhibits MAP kinase kinase (MEK) activity, p42 MAPK and p44 MAPK; structure in first source
2-(2-amino-3-methoxyphenyl)chromen-4-one : A member of the class of monomethoxyflavones that is 3'-methoxyflavone bearing an additional amino substituent at position 2'.
Excerpt | Relevance | Reference |
---|---|---|
"Human hepatocellular carcinoma (HCC) cell lines SMMC7721 and Huh7 were used." | 1.39 | Insufficient radiofrequency ablation promotes epithelial-mesenchymal transition of hepatocellular carcinoma cells through Akt and ERK signaling pathways. ( Ding, X; Dong, S; Gao, J; Ke, S; Kong, F; Kong, J; Sun, W; Wang, S; Zheng, L, 2013) |
"EMT in prostate cancer induced by FGF8b can be mediated by ERK kinase pathway, in which mitogen-activated/extraceluer signal regulated kinase 1 (MEK1) may be a key factor." | 1.38 | [Molecular mechanism of FGF8b regulation of epithelial-mesenchymal transition in prostate cancer cells]. ( Fan, B; Li, Z; Liu, H; Qi, F; Wang, G, 2012) |
"Metastatic breast cancer cells frequently and ectopically express the transcription factor RUNX2, which normally attenuates proliferation and promotes maturation of osteoblasts." | 1.36 | Cancer-related ectopic expression of the bone-related transcription factor RUNX2 in non-osseous metastatic tumor cells is linked to cell proliferation and motility. ( Cool, SM; Dobson, JR; Goh, X; Ito, Y; Kwok, HS; Leong, DT; Lian, JB; Lim, J; Nathan, SS; Pereira, BP; Pratap, J; Salto-Tellez, M; Stein, GS; van Wijnen, AJ; Voorhoeve, PM, 2010) |
"The human hepatocellular carcinoma (HCC)-derived cell line KYN-2 is thought to provide a good model for studying the molecular basis of invasion and metastasis of human HCC, because it often shows cell scattering in vitro and intrahepatic metastasis in vivo." | 1.33 | MEK/ERK signaling is a critical mediator for integrin-induced cell scattering in highly metastatic hepatocellular carcinoma cells. ( Aoyagi, Y; Genda, T; Honma, N; Ichida, T; Matsuda, Y; Takamura, M; Yamagiwa, S, 2006) |
"Primary cancer of the gallbladder is not unusual." | 1.32 | A MEK inhibitor (U0126) markedly inhibits direct liver invasion of orthotopically inoculated human gallbladder cancer cells in nude mice. ( Ajiki, T; Fujimori, T; Furihata, T; Hori, H; Horiuchi, H; Kawamata, H; Kuroda, Y; Ohkura, Y; Omotehara, F; Shinagawa, Y; Tachibana, M; Yamazaki, T, 2004) |
"[1986] Invasion Metastasis 6:302-12; Urtreger et al." | 1.31 | Heregulin inhibits proliferation via ERKs and phosphatidyl-inositol 3-kinase activation but regulates urokinase plasminogen activator independently of these pathways in metastatic mammary tumor cells. ( Aguirre Ghiso, J; Bal de Kier Joffé, E; Balañá, ME; Charreau, EH; Elizalde, PV; Labriola, L; Lupu, R; Pignataro, OP; Proietti, CJ; Proiettii, CJ; Puricelli, L; Salatino, M, 2002) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (8.00) | 18.2507 |
2000's | 12 (48.00) | 29.6817 |
2010's | 9 (36.00) | 24.3611 |
2020's | 2 (8.00) | 2.80 |
Authors | Studies |
---|---|
Chen, Y | 1 |
Liu, P | 1 |
Shen, D | 2 |
Liu, H | 2 |
Xu, L | 2 |
Wang, J | 3 |
Sun, H | 1 |
Wu, H | 1 |
Ren, J | 2 |
Wang, Y | 1 |
Ware, T | 1 |
Iaria, J | 1 |
Ten Dijke, P | 1 |
Zhu, HJ | 1 |
Ishay-Ronen, D | 1 |
Diepenbruck, M | 1 |
Kalathur, RKR | 1 |
Sugiyama, N | 1 |
Tiede, S | 1 |
Ivanek, R | 1 |
Bantug, G | 1 |
Morini, MF | 1 |
Hess, C | 1 |
Christofori, G | 1 |
Dong, S | 1 |
Kong, J | 2 |
Kong, F | 1 |
Gao, J | 2 |
Ke, S | 1 |
Wang, S | 1 |
Ding, X | 1 |
Sun, W | 1 |
Zheng, L | 1 |
Zhou, X | 1 |
Qi, Y | 1 |
Ko, SY | 1 |
Ko, HA | 1 |
Shieh, TM | 1 |
Chang, WC | 1 |
Chen, HI | 1 |
Chang, SS | 1 |
Lin, IH | 1 |
Koh, SA | 1 |
Lee, KH | 2 |
Shen, XY | 1 |
Wang, SH | 1 |
Liang, ML | 1 |
Wang, HB | 1 |
Xiao, L | 1 |
Wang, ZH | 1 |
Leong, DT | 1 |
Lim, J | 1 |
Goh, X | 1 |
Pratap, J | 1 |
Pereira, BP | 1 |
Kwok, HS | 1 |
Nathan, SS | 1 |
Dobson, JR | 1 |
Lian, JB | 1 |
Ito, Y | 1 |
Voorhoeve, PM | 1 |
Stein, GS | 1 |
Salto-Tellez, M | 1 |
Cool, SM | 1 |
van Wijnen, AJ | 1 |
Li, J | 2 |
Jia, L | 1 |
Zhao, P | 1 |
Jiang, Y | 1 |
Zhong, S | 1 |
Chen, D | 1 |
Pan, G | 1 |
Zhang, X | 1 |
Lu, J | 1 |
Li, W | 1 |
Fu, H | 1 |
Zhang, S | 1 |
Fan, B | 1 |
Wang, G | 1 |
Qi, F | 1 |
Li, Z | 1 |
Puricelli, L | 1 |
Proietti, CJ | 1 |
Proiettii, CJ | 1 |
Labriola, L | 1 |
Salatino, M | 1 |
Balañá, ME | 1 |
Aguirre Ghiso, J | 1 |
Lupu, R | 1 |
Pignataro, OP | 1 |
Charreau, EH | 1 |
Bal de Kier Joffé, E | 1 |
Elizalde, PV | 1 |
Mariano-Oliveira, A | 1 |
Coelho, AL | 1 |
Terruggi, CH | 1 |
Selistre-de-Araújo, HS | 1 |
Barja-Fidalgo, C | 1 |
De Freitas, MS | 1 |
Yoo, YG | 1 |
Yeo, MG | 1 |
Kim, DK | 1 |
Park, H | 1 |
Lee, MO | 1 |
Deng, X | 1 |
Horiuchi, H | 1 |
Kawamata, H | 1 |
Furihata, T | 1 |
Omotehara, F | 1 |
Hori, H | 1 |
Shinagawa, Y | 1 |
Ohkura, Y | 1 |
Tachibana, M | 1 |
Yamazaki, T | 1 |
Ajiki, T | 1 |
Kuroda, Y | 1 |
Fujimori, T | 1 |
Choi, EY | 1 |
Kim, MK | 1 |
Hyun, MS | 1 |
Jang, BI | 1 |
Kim, TN | 1 |
Kim, SW | 1 |
Song, SK | 1 |
Kim, JH | 1 |
Kim, JR | 1 |
Honma, N | 1 |
Genda, T | 1 |
Matsuda, Y | 1 |
Yamagiwa, S | 1 |
Takamura, M | 1 |
Ichida, T | 1 |
Aoyagi, Y | 1 |
Pan, Y | 1 |
Zhao, L | 1 |
Liang, J | 1 |
Liu, J | 1 |
Shi, Y | 1 |
Liu, N | 1 |
Zhang, G | 1 |
Jin, H | 1 |
Xie, H | 1 |
Liu, Z | 1 |
Fan, D | 1 |
Jeney, A | 1 |
Kenessey, I | 1 |
Timár, F | 1 |
Oláh, J | 1 |
Pogány, G | 1 |
Babó, I | 1 |
Harisi, R | 1 |
Saha, S | 1 |
Chowdhury, P | 1 |
Pal, A | 1 |
Chakrabarti, MK | 1 |
Zhou, JN | 2 |
Ljungdahl, S | 1 |
Shoshan, MC | 3 |
Swedenborg, J | 1 |
Linder, S | 3 |
Seddighzadeh, M | 2 |
Kronenwett, U | 1 |
Auer, G | 2 |
Sten-Linder, M | 1 |
Wiman, B | 1 |
Alaiya, AA | 1 |
1 review available for pd 98059 and Metastase
Article | Year |
---|---|
[Study of drugs against neoplastic metastasis].
Topics: Animals; Antineoplastic Agents; Cell Movement; Chromones; Deoxyuridine; Doxorubicin; Enzyme Inhibito | 2006 |
24 other studies available for pd 98059 and Metastase
Article | Year |
---|---|
FAM172A inhibits EMT in pancreatic cancer via ERK-MAPK signaling.
Topics: Adult; Aged; Cadherins; Cell Line, Tumor; Epithelial-Mesenchymal Transition; Female; Flavonoids; Gen | 2020 |
Reactivation of BMP signaling by suboptimal concentrations of MEK inhibitor and FK506 reduces organ-specific breast cancer metastasis.
Topics: Animals; Bone Morphogenetic Proteins; Breast Neoplasms; Butadienes; Cell Line, Tumor; Cell Prolifera | 2020 |
Gain Fat-Lose Metastasis: Converting Invasive Breast Cancer Cells into Adipocytes Inhibits Cancer Metastasis.
Topics: 3T3-L1 Cells; Adipocytes; Adipogenesis; Animals; Breast Neoplasms; Cell Line, Tumor; Cell Movement; | 2019 |
Insufficient radiofrequency ablation promotes epithelial-mesenchymal transition of hepatocellular carcinoma cells through Akt and ERK signaling pathways.
Topics: Animals; Carcinoma, Hepatocellular; Catheter Ablation; Cell Line, Tumor; Chromones; Disease Progress | 2013 |
PLGF inhibition impairs metastasis of larynx carcinoma through MMP3 downregulation.
Topics: Blotting, Western; Cell Line, Tumor; Down-Regulation; Flavonoids; Gene Expression Regulation, Neopla | 2014 |
Cell migration is regulated by AGE-RAGE interaction in human oral cancer cells in vitro.
Topics: Adult; Cell Line, Tumor; Cell Movement; Cell Proliferation; Diabetes Complications; Diabetes Mellitu | 2014 |
HGF mediated upregulation of lipocalin 2 regulates MMP9 through nuclear factor-κB activation.
Topics: Acute-Phase Proteins; Cell Line; Cell Proliferation; Chromones; Flavonoids; Gene Expression Regulati | 2015 |
[The role and mechanism of CXCR4 and its ligand SDF-1 in the development of cervical cancer metastasis].
Topics: Calcium; Calcium-Calmodulin-Dependent Protein Kinases; Cell Adhesion; Chemokine CXCL12; Extracellula | 2008 |
Cancer-related ectopic expression of the bone-related transcription factor RUNX2 in non-osseous metastatic tumor cells is linked to cell proliferation and motility.
Topics: Adenocarcinoma; Biomarkers, Tumor; Breast Neoplasms; Cell Line, Tumor; Cell Movement; Cell Prolifera | 2010 |
Stable knockdown of clusterin by vectorbased RNA interference in a human breast cancer cell line inhibits tumour cell invasion and metastasis.
Topics: Animals; Breast Neoplasms; Cell Line, Tumor; Cell Movement; Cell Proliferation; Clusterin; Extracell | 2012 |
Semaphorin 5A, an axon guidance molecule, enhances the invasion and metastasis of human gastric cancer through activation of MMP9.
Topics: Analysis of Variance; Cell Line, Tumor; Cell Movement; Flavonoids; Humans; Integrins; MAP Kinase Sig | 2013 |
[Molecular mechanism of FGF8b regulation of epithelial-mesenchymal transition in prostate cancer cells].
Topics: Epithelial-Mesenchymal Transition; Fibroblast Growth Factor 8; Flavonoids; Humans; Male; MAP Kinase | 2012 |
Heregulin inhibits proliferation via ERKs and phosphatidyl-inositol 3-kinase activation but regulates urokinase plasminogen activator independently of these pathways in metastatic mammary tumor cells.
Topics: Animals; Blotting, Western; Cell Division; Cell Movement; Dimerization; Dose-Response Relationship, | 2002 |
Alternagin-C, a nonRGD-disintegrin, induces neutrophil migration via integrin signaling.
Topics: Actins; Active Transport, Cell Nucleus; Amino Acid Motifs; Animals; Bothrops; Cell Movement; Cell Nu | 2003 |
Novel function of orphan nuclear receptor Nur77 in stabilizing hypoxia-inducible factor-1alpha.
Topics: Animals; Blotting, Western; Cell Line; Cell Line, Tumor; Cell Nucleus; Disease Progression; DNA-Bind | 2004 |
Tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone induces phosphorylation of mu- and m-calpain in association with increased secretion, cell migration, and invasion.
Topics: Blotting, Western; Calpain; Carcinogens; Cell Line, Tumor; Cell Movement; Disease Progression; Dose- | 2004 |
A MEK inhibitor (U0126) markedly inhibits direct liver invasion of orthotopically inoculated human gallbladder cancer cells in nude mice.
Topics: Animals; Butadienes; Cell Line, Tumor; Cell Survival; Enzyme Inhibitors; Flavonoids; Gallbladder Neo | 2004 |
Regulation of hepatocyte growth factor-mediated urokinase plasminogen activator secretion by MEK/ERK activation in human stomach cancer cell lines.
Topics: Cell Line, Tumor; Cell Proliferation; Culture Media, Serum-Free; Dose-Response Relationship, Drug; E | 2006 |
MEK/ERK signaling is a critical mediator for integrin-induced cell scattering in highly metastatic hepatocellular carcinoma cells.
Topics: Actin Cytoskeleton; Cadherins; Carcinoma, Hepatocellular; Cell Adhesion; Cell Culture Techniques; Ce | 2006 |
Cellular prion protein promotes invasion and metastasis of gastric cancer.
Topics: Animals; Calcium-Calmodulin-Dependent Protein Kinases; CD8-Positive T-Lymphocytes; Cell Adhesion; En | 2006 |
Downregulation of human colon carcinoma cell (COLO-205) proliferation through PKG-MAP kinase mediated signaling cascade by E. coli heat stable enterotoxin (STa), a potent anti-angiogenic and anti-metastatic molecule.
Topics: Aminoquinolines; Angiogenesis Inhibitors; Bacterial Toxins; Blotting, Western; Carbazoles; Cell Line | 2008 |
Activation of tissue-factor gene expression in breast carcinoma cells by stimulation of the RAF-ERK signaling pathway.
Topics: Base Sequence; Benzoquinones; Breast Neoplasms; Calcium-Calmodulin-Dependent Protein Kinases; Dactin | 1998 |
ERK signalling in metastatic human MDA-MB-231 breast carcinoma cells is adapted to obtain high urokinase expression and rapid cell proliferation.
Topics: Breast Neoplasms; Cell Division; Cyclin D1; Cyclin-Dependent Kinase Inhibitor p21; Cyclins; Enzyme I | 1999 |
Inhibition of extracellular signal-regulated kinase 1/2 activity of the breast cancer cell line MDA-MB-231 leads to major alterations in the pattern of protein expression.
Topics: Breast Neoplasms; Cell Division; Dose-Response Relationship, Drug; Electrophoresis, Gel, Two-Dimensi | 2000 |